Maxcyte (MXCT) Revenue (2020 - 2026)

Maxcyte (MXCT) reported Revenue of $9.7 million for Q1 2026, up 68.05% year-over-year from $5.7 million in Q1 2025, and up 302.37% on a QoQ basis from -$4.8 million in Q4 2025.

Maxcyte (MXCT) has 7 years of Revenue data on file, last reported at $9.7 million in Q1 2026.

  • Quarterly Revenue rose 68.05% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (down 36.38% YoY) and the FY2025 annual result came in at $21.0 million, down 45.75% from the prior year.
  • Revenue improved to $9.7 million in Q1 2026 per MXCT's latest filing, from -$4.8 million in the prior quarter.
  • Across five years, Revenue topped out at $11.6 million in Q1 2022 and bottomed at -$4.8 million in Q4 2025.
  • The 5-year median for Revenue is $5.8 million (2025), against an average of $5.8 million.
  • The widest annual swing landed in 2023, when Revenue jumped 253.92%; it then tumbled 154.86% in 2025.
  • Tracing MXCT's Revenue over 5 years: stood at -$3.1 million in 2022, then jumped by 253.92% to $4.8 million in 2023, then soared by 82.78% to $8.7 million in 2024, then plunged by 154.86% to -$4.8 million in 2025, then surged by 302.37% to $9.7 million in 2026.
  • Per Business Quant, the three latest MXCT Revenue figures stand at $9.7 million (Q1 2026), -$4.8 million (Q4 2025), and $6.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn 9.65 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.65 Mn
Dec 31, 2025 -4.77 Mn
Sep 30, 2025 6.83 Mn
Jun 30, 2025 5.82 Mn
Mar 31, 2025 5.74 Mn
Dec 31, 2024 8.69 Mn
Sep 30, 2024 8.16 Mn
Jun 30, 2024 4.96 Mn
Mar 31, 2024 5.58 Mn
Dec 31, 2023 4.76 Mn
Sep 30, 2023 4.16 Mn
Jun 30, 2023 9.04 Mn
Mar 31, 2023 4.96 Mn
Dec 31, 2022 -3.09 Mn
Sep 30, 2022 7.15 Mn
Jun 30, 2022 9.61 Mn
Mar 31, 2022 11.59 Mn
Dec 31, 2021 -2.17 Mn
Sep 30, 2021 5.61 Mn
Jun 30, 2021 7.11 Mn
Mar 31, 2021 4.24 Mn
Dec 31, 2020 -2.20 Mn
Sep 30, 2020 4.67 Mn
Jun 30, 2020 2.33 Mn